← Open Payments lookup

DAN IOANITESCU: Open Payments

NPI 1720024292 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,131 in 55 payments from 16 companies in 2025. Trend: 2023 $659 · 2024 $1,013 · 2025 $1,131

Food & beverage: $1,131
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.7$209
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$189
Otsuka America Pharmaceutical, Inc.8$143
Alkermes, Inc.4$96
Vanda Pharmaceuticals Inc.5$94
ABBVIE INC.3$71
E.R. Squibb & Sons, L.L.C.2$48
Axsome Therapeutics, Inc.2$42
Takeda Pharmaceuticals U.S.A., Inc.2$42
Noven Therapeutics, LLC2$41

Products named: INGREZZA, CAPLYTA, REXULTI, ARISTADA, FANAPT, VRAYLAR, COBENFY, Auvelity.

Industry payments across GA — which companies pay providers there.